Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hoadley

Showing results (151-160 of 191) with videos related to

Pageof 20
Sort By:
Science (New York, N.Y.)|October 27, 2018
The chromatin accessibility landscape of primary human cancersM Ryan Corces, Jeffrey M Granja, Shadi Shams, et al.
Cell|April 17, 2012
Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancerJames S Duncan, Martin C Whittle, Kazuhiro Nakamura, et al.
Cancer Cell|May 13, 2020
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in CancerJian Carrot-Zhang, Nyasha Chambwe, Jeffrey S Damrauer, et al.
Cancer Cell|April 20, 2010
Identification of a CpG island methylator phenotype that defines a distinct subgroup of gliomaHoutan Noushmehr, Daniel J Weisenberger, Kristin Diefes, et al.
European Urology|September 30, 2019
A Consensus Molecular Classification of Muscle-invasive Bladder CancerAurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al.
Cancer Cell|January 3, 2025
Classification of non-TCGA cancer samples to TCGA molecular subtypes using compact feature setsKyle Ellrott, Christopher K Wong, Christina Yau, et al.
Cell|October 10, 2015
Comprehensive Molecular Portraits of Invasive Lobular Breast CancerGiovanni Ciriello, Michael L Gatza, Andrew H Beck, et al.
The Journal of Pathology|November 19, 2016
The molecular basis of breast cancer pathological phenotypesYujing J Heng, Susan C Lester, Gary Mk Tse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2022
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast CancerJonathan H Shepherd, Karla Ballman, Mei-Yin C Polley, et al.
Cancer Cell|February 5, 2010
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, et al.
Pageof 20

Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
Science (New York, N.Y.)|October 27, 2018
The chromatin accessibility landscape of primary human cancersM Ryan Corces, Jeffrey M Granja, Shadi Shams, et al.
Cell|April 17, 2012
Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancerJames S Duncan, Martin C Whittle, Kazuhiro Nakamura, et al.
Cancer Cell|May 13, 2020
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in CancerJian Carrot-Zhang, Nyasha Chambwe, Jeffrey S Damrauer, et al.
Cancer Cell|April 20, 2010
Identification of a CpG island methylator phenotype that defines a distinct subgroup of gliomaHoutan Noushmehr, Daniel J Weisenberger, Kristin Diefes, et al.
European Urology|September 30, 2019
A Consensus Molecular Classification of Muscle-invasive Bladder CancerAurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al.
Cancer Cell|January 3, 2025
Classification of non-TCGA cancer samples to TCGA molecular subtypes using compact feature setsKyle Ellrott, Christopher K Wong, Christina Yau, et al.
Cell|October 10, 2015
Comprehensive Molecular Portraits of Invasive Lobular Breast CancerGiovanni Ciriello, Michael L Gatza, Andrew H Beck, et al.
The Journal of Pathology|November 19, 2016
The molecular basis of breast cancer pathological phenotypesYujing J Heng, Susan C Lester, Gary Mk Tse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2022
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast CancerJonathan H Shepherd, Karla Ballman, Mei-Yin C Polley, et al.
Cancer Cell|February 5, 2010
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, et al.
Pageof 20